CustomSurg wins CHF 150,000 to optimize orthopedic surgery with 3D simulations and augmented reality
20.05.2021
Complex bone fractures lead to a significant decrease in quality of life and loss of productivity. CustomSurg turns current subjective clinical treatments into a biomechanical, data-driven process that makes surgeries more efficient through advanced planning and assistance services and will provide patient-specific implants. The Zurich-based medtech solution optimizes each bone fracture case to ensure safe and effective bone reconstructions, faster surgeries and recovery, and fewer complications. CustomSurg will use the CHF 150,000 to run clinical feasibility studies and fundraising activities
 The CustomSurg team (from left to right): Arvind von Keudell, Valentin Splett, Thomas Zumbrunn
|
 |
One in four surgeries after complex bone fractures results in patients suffering from complications and long-term disabilities. Even though modern implants have improved the capability of fixing and securing fractures, treatment decisions are highly subjective, and a large amount of intraoperative “trial and error” is involved in complex fractures. The currently unknown stability of a given fracture construct leads to patient immobilization times of up to three months after surgery.
CustomSurg’s service model provides a fully customized solution for a personalized treatment strategy based on patient-specific, biomechanical data. The startup’s technology uses a CT scan to generate 3D models and mimic daily activities through real-life load simulations. This process enables CustomSurg to optimize screws and implant positioning for the specific fracture. Being able to quantify the stability of a given fracture construct will allow patients to get back on their feet faster. Through 3D-printed bone models and augmented reality assistance, the surgeons get objective pre-operative planning and intra-operative assistance. CustomSurg’s technology will initially be developed for complex knee surgery and eventually tackle a total addressable market of USD 1.4 billion.
The CustomSurg project was launched in 2019 by Dr. sc. Thomas Zumbrunn (team lead and co-inventor), Dr. med. Arvind von Keudell (medical lead and co-inventor), and Valentin Splett (commercial lead). The startup is currently being incorporated and will use the CHF 150,000 to run clinical feasibility studies and raise the funds needed to finalize the product and obtain regulatory approval. “Besides the financial support, allowing the generation of prototypes for market validation, feedback, and connections by Venture Kick jury and staff with an ecosystem of accomplished industry executives has been a tremendous benefit for CustomSurg,” said Thomas Zumbrunn, co-Founder and CEO of CustomSurg.
The CustomSurg team (from left to right): Arvind von Keudell, Valentin Splett, Thomas Zumbrunn
CustomSurg’s service model provides a fully customized solution for a personalized treatment strategy based on patient-specific, biomechanical data. The startup’s technology uses a CT scan to generate 3D models and mimic daily activities through real-life load simulations. This process enables CustomSurg to optimize screws and implant positioning for the specific fracture. Being able to quantify the stability of a given fracture construct will allow patients to get back on their feet faster. Through 3D-printed bone models and augmented reality assistance, the surgeons get objective pre-operative planning and intra-operative assistance. CustomSurg’s technology will initially be developed for complex knee surgery and eventually tackle a total addressable market of USD 1.4 billion.
The CustomSurg project was launched in 2019 by Dr. sc. Thomas Zumbrunn (team lead and co-inventor), Dr. med. Arvind von Keudell (medical lead and co-inventor), and Valentin Splett (commercial lead). The startup is currently being incorporated and will use the CHF 150,000 to run clinical feasibility studies and raise the funds needed to finalize the product and obtain regulatory approval. “Besides the financial support, allowing the generation of prototypes for market validation, feedback, and connections by Venture Kick jury and staff with an ecosystem of accomplished industry executives has been a tremendous benefit for CustomSurg,” said Thomas Zumbrunn, co-Founder and CEO of CustomSurg.
The CustomSurg team (from left to right): Arvind von Keudell, Valentin Splett, Thomas Zumbrunn